APA (7th ed.) Citation

Xiang, Z., Li, W., & Xia, Q. (2025). Cadonilimab in combination with chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: A cost-effectiveness analysis. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Xiang, Zuojuan, Wei Li, and Qiao Xia. Cadonilimab in Combination with Chemotherapy for HER2-negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Cost-effectiveness Analysis. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Xiang, Zuojuan, et al. Cadonilimab in Combination with Chemotherapy for HER2-negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Cost-effectiveness Analysis. Frontiers Media S.A, 2025.